Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 124.575 USD -2.41% Market Closed
Market Cap: 7.7B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jazz Pharmaceuticals PLC
Total Equity Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Total Equity
$4.2B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
12%
Perrigo Company PLC
NYSE:PRGO
Total Equity
$4.6B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Total Equity
$70.3m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
2%
G
GH Research PLC
NASDAQ:GHRS
Total Equity
$219m
CAGR 3-Years
237%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Total Equity
€498.4m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
11%
Ovoca Bio PLC
LSE:OVB
Total Equity
€2.2m
CAGR 3-Years
-48%
CAGR 5-Years
-36%
CAGR 10-Years
-22%

See Also

What is Jazz Pharmaceuticals PLC's Total Equity?
Total Equity
4.2B USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Total Equity amounts to 4.2B USD.

What is Jazz Pharmaceuticals PLC's Total Equity growth rate?
Total Equity CAGR 10Y
12%

Over the last year, the Total Equity growth was 20%. The average annual Total Equity growth rates for Jazz Pharmaceuticals PLC have been 2% over the past three years , 6% over the past five years , and 12% over the past ten years .

Back to Top